225 related articles for article (PubMed ID: 29314863)
1. Bacterial-derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease.
Richmond BW; Du RH; Han W; Benjamin JT; van der Meer R; Gleaves L; Guo M; McKissack A; Zhang Y; Cheng DS; Polosukhin VV; Blackwell TS
Am J Respir Cell Mol Biol; 2018 Jun; 58(6):736-744. PubMed ID: 29314863
[TBL] [Abstract][Full Text] [Related]
2. Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.
Richmond BW; Brucker RM; Han W; Du RH; Zhang Y; Cheng DS; Gleaves L; Abdolrasulnia R; Polosukhina D; Clark PE; Bordenstein SR; Blackwell TS; Polosukhin VV
Nat Commun; 2016 Apr; 7():11240. PubMed ID: 27046438
[TBL] [Abstract][Full Text] [Related]
3. Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling.
Polosukhin VV; Richmond BW; Du RH; Cates JM; Wu P; Nian H; Massion PP; Ware LB; Lee JW; Kononov AV; Lawson WE; Blackwell TS
Am J Respir Crit Care Med; 2017 Apr; 195(8):1010-1021. PubMed ID: 27911098
[TBL] [Abstract][Full Text] [Related]
4. Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease.
Polosukhin VV; Cates JM; Lawson WE; Zaynagetdinov R; Milstone AP; Massion PP; Ocak S; Ware LB; Lee JW; Bowler RP; Kononov AV; Randell SH; Blackwell TS
Am J Respir Crit Care Med; 2011 Aug; 184(3):317-27. PubMed ID: 21512171
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease.
Fritzsching B; Zhou-Suckow Z; Trojanek JB; Schubert SC; Schatterny J; Hirtz S; Agrawal R; Muley T; Kahn N; Sticht C; Gunkel N; Welte T; Randell SH; Länger F; Schnabel P; Herth FJ; Mall MA
Am J Respir Crit Care Med; 2015 Apr; 191(8):902-13. PubMed ID: 25607238
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological profile of roflumilast].
Cortijo Gimeno J; Morcillo Sánchez E
Arch Bronconeumol; 2010 Dec; 46 Suppl 10():19-24. PubMed ID: 21316552
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of roflumilast with dexamethasone in a neutrophilic asthma mouse model.
Park CK; An TJ; Kim JH; Rhee CK; Yoon HK
Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):624-632. PubMed ID: 35181901
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cells and chronic obstructive pulmonary disease.
Tetley TD
Curr Drug Targets Inflamm Allergy; 2005 Dec; 4(6):607-18. PubMed ID: 17305517
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection.
Kasetty G; Papareddy P; Bhongir RK; Egesten A
J Pharmacol Exp Ther; 2016 Apr; 357(1):66-72. PubMed ID: 26865680
[TBL] [Abstract][Full Text] [Related]
10. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD.
Pera T; Zuidhof A; Valadas J; Smit M; Schoemaker RG; Gosens R; Maarsingh H; Zaagsma J; Meurs H
Eur Respir J; 2011 Oct; 38(4):789-96. PubMed ID: 21349917
[TBL] [Abstract][Full Text] [Related]
11. Effect of roflumilast on airway remodelling in a murine model of chronic asthma.
Kim SW; Kim JH; Park CK; Kim TJ; Lee SY; Kim YK; Kwon SS; Rhee CK; Yoon HK
Clin Exp Allergy; 2016 May; 46(5):754-63. PubMed ID: 26542330
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-α.
Eurlings IM; Dentener MA; Mercken EM; de Cabo R; Bracke KR; Vernooy JH; Wouters EF; Reynaert NL
Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(7):L557-65. PubMed ID: 25106431
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease.
Wiegman CH; Li F; Ryffel B; Togbe D; Chung KF
Front Immunol; 2020; 11():1957. PubMed ID: 32983127
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation.
Tanabe N; Hoshino Y; Marumo S; Kiyokawa H; Sato S; Kinose D; Uno K; Muro S; Hirai T; Yodoi J; Mishima M
PLoS One; 2013; 8(11):e79016. PubMed ID: 24244404
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.
Lappalainen U; Whitsett JA; Wert SE; Tichelaar JW; Bry K
Am J Respir Cell Mol Biol; 2005 Apr; 32(4):311-8. PubMed ID: 15668323
[TBL] [Abstract][Full Text] [Related]
16. Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease.
Dunne AE; Kawamatawong T; Fenwick PS; Davies CM; Tullett H; Barnes PJ; Donnelly LE
Am J Respir Cell Mol Biol; 2019 Apr; 60(4):445-453. PubMed ID: 30395484
[TBL] [Abstract][Full Text] [Related]
17. Secretory Cells Are the Primary Source of pIgR in Small Airways.
Blackburn JB; Schaff JA; Gutor S; Du RH; Nichols D; Sherrill T; Gutierrez AJ; Xin MK; Wickersham N; Zhang Y; Holtzman MJ; Ware LB; Banovich NE; Kropski JA; Blackwell TS; Richmond BW
Am J Respir Cell Mol Biol; 2022 Sep; 67(3):334-345. PubMed ID: 35687143
[TBL] [Abstract][Full Text] [Related]
18. Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease.
Lu Z; Van Eeckhoutte HP; Liu G; Nair PM; Jones B; Gillis CM; Nalkurthi BC; Verhamme F; Buyle-Huybrecht T; Vandenabeele P; Vanden Berghe T; Brusselle GG; Horvat JC; Murphy JM; Wark PA; Bracke KR; Fricker M; Hansbro PM
Am J Respir Crit Care Med; 2021 Sep; 204(6):667-681. PubMed ID: 34133911
[No Abstract] [Full Text] [Related]
19. Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice.
De Cunto G; Brancaleone V; Riemma MA; Cerqua I; Vellecco V; Spaziano G; Cavarra E; Bartalesi B; D'Agostino B; Lungarella G; Cirino G; Lucattelli M; Roviezzo F
Br J Pharmacol; 2020 Jan; 177(2):267-281. PubMed ID: 31499592
[TBL] [Abstract][Full Text] [Related]
20. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
